Skip to main content
# Title Department Research Year
191 Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity Department of Pharmaceutical Organic Chemistry 2023
192 Impact of the functional coating of silver nanoparticles on their in vivo performance and biosafety Department of Industrial Pharmacy 2023
193 COVID-19 associated Mucormycosis among ICU patients: risk factors, control, and challenges 2023
194 Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents Department of Pharmaceutical Organic Chemistry 2023
195 Selective detection of rutin at novel pyridinic-nitrogen-rich carbon dots derived from chicken feet biowaste: The role of bovine serum albumin during the assay Department of Pharmaceutical Analytical Chemistry 2023
196 Synthesis, biological evaluation and molecular docking study of some new 4-aminosalicylic acid derivatives as anti-inflammatory and antimycobacterial agents Department of Pharmaceutical Organic Chemistry 2023
197 New 1,2,3-Triazole/1,2,4-triazole Hybrids as Aromatase Inhibitors: Design, Synthesis, and Apoptotic Antiproliferative Activity Department of Pharmaceutical Organic Chemistry 2023
198 Synthesis and antiproliferative Potential of thiazole and 4-thiazolidinone Containing Motifs as dual inhibitors of EGFR and BRAFV600E Department of Pharmaceutical Organic Chemistry 2023
199 Chitosan-capped silver nanoparticles with potent and selective intrinsic activity against the breast cancer cells Department of Industrial Pharmacy 2023
200 Phage therapy, a salvage treatment for multidrug-resistant bacteria causing infective endocarditis 2023